STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Real Brokerage Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Real Brokerage Inc (REAX) notice reports a proposed sale of 7,606 common shares acquired as Restricted Stock Units on 09/13/2025. The filing names Morgan Stanley Smith Barney LLC as the broker and lists an aggregate market value of $38,714.54 for the shares, with an approximate sale date of 09/16/2025 on NASDAQ. The form states total shares outstanding of 209,300,000, making the proposed sale a very small fraction of the company’s outstanding equity.

The filing also discloses prior Rule 10b5-1 sales for the same account: 43,048 shares sold on 08/25/2025 for gross proceeds of $215,270.13. The seller represents compliance with Rule 144 and affirms no undisclosed material adverse information. The securities were acquired from the issuer as RSUs and paid on the acquisition date 09/13/2025.

Positive
  • Transaction is immaterial relative to the 209,300,000 shares outstanding, implying negligible market impact
  • Broker and sale details provided (Morgan Stanley Smith Barney LLC, NASDAQ), supporting transparency
  • Prior 10b5-1 sales disclosed, indicating use of preplanned trading arrangements
Negative
  • None.

Insights

TL;DR: Proposed sale is immaterial relative to outstanding shares and follows RSU vesting; prior 10b5-1 sales also small.

The proposed sale of 7,606 shares valued at $38,714.54 equals roughly 0.0036% of the 209.3 million shares outstanding, indicating negligible dilution or market impact. The shares originate from Restricted Stock Units vested on 09/13/2025, a routine executive compensation outcome rather than an operational signal. The earlier 10b5-1 sale of 43,048 shares on 08/25/2025 for $215,270.13 suggests ongoing pre-planned dispositions rather than ad hoc large-scale liquidation. Overall, these amounts are immaterial to company valuation but informative about insider liquidity events.

TL;DR: Filing appears procedurally standard and includes 10b5-1 disclosure and required representations.

The form names the executing broker and specifies acquisition as RSUs from the issuer with acquisition and payment on 09/13/2025, and it references the seller’s representation about absence of undisclosed material information. Prior 10b5-1 sales are disclosed, which supports compliance with planned trading frameworks. No indications of missing attestations or unusual payment arrangements are present in the provided text. The filing follows procedural requirements for Rule 144 notices.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares of REAX are proposed for sale in this Form 144?

The filing proposes sale of 7,606 common shares acquired as Restricted Stock Units on 09/13/2025.

What is the aggregate market value and approximate sale date for the proposed REAX sale?

Aggregate market value is reported as $38,714.54 with an approximate sale date of 09/16/2025 on NASDAQ.

Who is the executing broker named in the REAX Form 144?

The broker listed is Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, New York, NY).

Were there any recent sales by the same account disclosed?

Yes; a Rule 10b5-1 sale of 43,048 shares occurred on 08/25/2025 for gross proceeds of $215,270.13.

How material is this proposed sale relative to REAX’s outstanding shares?

The proposed 7,606-share sale represents a very small fraction of the 209,300,000 shares outstanding, indicating minimal market impact.
Real Brokerage

NASDAQ:REAX

REAX Rankings

REAX Latest News

REAX Latest SEC Filings

REAX Stock Data

868.38M
171.29M
19.05%
37.27%
1.14%
Real Estate Services
Real Estate
Link
United States
Miami